Icosavax Inc (ICVX) Peer Comparison

$15.31

$0.00 (0.00%)

As on 29-Feb-2024 09:30EDT

Market cap

$769 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.3

Div. Yield

0 %

Edit

	Icosavax Inc (ICVX)	Harpoon Therapeutics (HARP)	Karuna Therapeutics (KRTX)
Market cap ($ Mln)	769	492	12,599
Revenue ($ Mln)	--	37	1
Net Profit ($ Mln)	-92.62	-30.87	-433.68
Net Margin (%)	--	-82.66	-3,475.94
RoE (%)	-42.83	-1,174.47	-36.44
Price to Earnings	--	--	--
Price-To-Book	3.31	108.42	10.05

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Icosavax Inc (ICVX)	Harpoon Therapeutics (HARP)	Karuna Therapeutics (KRTX)
Operating Revenue	0.00	37.34	0.65
Cost of Revenue	3.67	2.82	1.70
Gross Profit	-1.26	31.92	10.64
Operating Expenses	105.88	74.74	495.43
Operating Profit (EBIT)	-105.88	-39.12	-494.78
Other Income	0.00	0.00	11.49
Profit before Tax	-96.71	-30.50	-433.01
Provision for Tax	-5.52	1.20	-45.30
Profit after Tax (Net Income)	-92.62	-30.87	-422.19
Minority Interest	0.00	0.00	0.00
Consolidated Profit	-74.67	-16.30	-200.74

Liabilities ($ Mln)

	Icosavax Inc (ICVX)	Harpoon Therapeutics (HARP)	Karuna Therapeutics (KRTX)
Shareholder's Funds	232.38	4.54	1,254.24
Minority Interest	0.00	0.00	0.00
Non-Current Liabilities	5.89	24.93	13.85
Current Liabilities	13.03	18.11	68.13
Total Liabilities	238.68	73.73	1,163.33

Assets ($ Mln)

	Icosavax Inc (ICVX)	Harpoon Therapeutics (HARP)	Karuna Therapeutics (KRTX)
Non-Current Assets	15.99	13.28	20.90
Current Assets	235.31	34.30	1,315.31
Total Assets	238.68	73.73	1,163.33
Total Debt*	8.07	14.50	16.69
Net Current Assets	222.28	16.19	1,247.18

Cashflow ($ Mln)

	Icosavax Inc (ICVX)	Harpoon Therapeutics (HARP)	Karuna Therapeutics (KRTX)
Cash From Operating Activities	-61.68	-89.18	-228.01
Cash Flow from Investing Activities	--	89.74	-586.40
Cash from Financing Activities	10.31	6.37	855.78
Net Cash Inflow / Outflow	--	--	41.38

Ratios

Profitability Ratios

	Icosavax Inc (ICVX)	Harpoon Therapeutics (HARP)	Karuna Therapeutics (KRTX)
ROCE (%)	-35.02	-146.49	-33.68
ROE (%)	-42.83	-1,174.47	-31.58
ROA (%)	-35.54	-30.37	-32.46
EBIT Margin (%)	--	-102.25	-75,845.72
Net Margin (%)	-15,198.97	-82.66	-3,475.94
Cash Profit Margin (%)	--	0.00	-0.04

Growth Ratios

	Icosavax Inc (ICVX)	Harpoon Therapeutics (HARP)	Karuna Therapeutics (KRTX)
Revenue Growth (%)	-0.93	16.14	-93.85
EBIT Growth (%)	-23.13	46.34	-71.06
Net Profit Growth (%)	-9.55	56.26	-57.65
EPS Growth (%)	1.02	58.97	-32.01
Book Value Growth (%)	-18.19	-77.51	-3.68

Valuation Ratios

	Icosavax Inc (ICVX)	Harpoon Therapeutics (HARP)	Karuna Therapeutics (KRTX)
Price / Earnings	-3.57	-0.04	-22.75
Price / Book Value	1.45	0.45	5.58
Dividend Yield (%)	--	--	--
EV/EBITDA	-1.13	0.53	-17.91
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Icosavax Inc (ICVX)	Harpoon Therapeutics (HARP)	Karuna Therapeutics (KRTX)
Debt to Equity	0.00	0.00	0.00
Short term debt to equity ratio	0.01	0.65	0.00
Current Ratio	18.06	1.89	19.31
Quick Ratio	18.06	1.89	18.82
Interest Coverage	-33.84	-6.46	-17.84

Operating Efficiency Ratios

	Icosavax Inc (ICVX)	Harpoon Therapeutics (HARP)	Karuna Therapeutics (KRTX)
Debtors to sales (%)	--	0.00	749.24
Asset Turnover	0.00	0.37	0.00
Receivable days	--	9.84	31.02
Inventory Days	--	--	8,081.81
Payable days	672.93	435.07	709.15
Cash Conversion Cycle	--	--	7,403.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly